Last reviewed · How we verify

NCT05637944: TRACTIONS

ThoRAciC Trauma IntubatiON Risk Score for Blunt Trauma

Status unknown Last updated 31 January 2024
What this trial tests

trial testing oro tracheal intubation in Trauma Chest in 1,000 participants. Status unknown.

Timeline
1 October 2022
Primary endpoint
1 October 2024
1 October 2024

Quick facts

Lead sponsorAzienda Usl di Bologna
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,000
Start date1 October 2022
Primary completion1 October 2024
Estimated completion1 October 2024
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Azienda Usl di Bologna — full company profile →

Who can join

18 and older, any sex, with Trauma Chest. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is the evaluation of risk factors associated with orotracheal intubation in blunt chest trauma patients not intubated on the field and not fulfilling the criteria for intubation based on the Glasgow Coma scale score with the building of a predictive score based on those findings taking into account the clinical, laboratory and radiologic tests performed within 6 hours from hospital admission.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Trauma Chest

Currently open trials in the same condition.

Other Azienda Usl di Bologna trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05637944.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing